{"name":"Cyclomedica Australia PTY Limited","slug":"cyclomedica-australia-pty-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Technegas","genericName":"Technegas","slug":"technegas","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Technegas","genericName":"Technegas","slug":"technegas","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQYURTckdlQlN5bGtuc2xBdmt4a3ZLcGwtYkdqZ1hFOHJFaFdfSmpfc0RrelJMNkxMSkhTYk9VZF81UDdxa1FFbW5OSGpSTUVzQnhZdkYxWVZUaFB3dWhab01TTnJ3NUktSzJRbC1IM1c4TjZaQm9kNWE3Rm4yTFV6TVQ5VGFUcTdhTDFoQVVSMXN6SFlvZFJzSjd0NVJXS24xMW12MDZaTWNCTFZuRXc?oc=5","date":"2021-05-05","type":"deal","source":"newswire.com","summary":"Jubilant Radiopharma and Cylcomedica Europe Announce Their Partnership for the Distribution of RUBY-FILL® During the International Conference on Nuclear Cardiology - newswire.com","headline":"Jubilant Radiopharma and Cylcomedica Europe Announce Their Partnership for the Distribution of RUBY-FILL® During the Int","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"discontinued":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}